Avita Medical



Ebitda تغيير تاريخ
Celltrion KRW 221.03B 57.43B 2025-03
Clinuvel Pharmaceuticals AUD 40.01M 21.64M 2024-06
Cochlear AUD 323M 24.1M 2024-12
CSL USD 3.23B 1.52B 2024-12
Cspc Pharmaceutical CNY 2.21B 275.77M 2023-12
Dianthus Therapeutics USD -31838000 1.96M 2024-12
Divis Laboratories Ltd 9.72B 2.29B 2025-03
Kangmei Pharma -3262057.35 15.91M 2024-09
Knight Therapeutics CAD 16.72M 1.05M 2024-09
Laboratorios Farma EUR 137.9M 93.62M 2024-12
Malin Corporation EUR -1100000 200K 2024-12
Mayne Pharma AUD -65761000 45.24M 2024-06
Medical Developments International AUD 1.78M 3.78M 2024-12
Nanosonics AUD 11.36M 2.36M 2024-12
Neuren Pharmaceuticals AUD 176.7M 166.79M 2024-12
Organigram Holdings CAD -16179000 63.98M 2024-12
Pacific Edge NZD -13968000 332K 2024-09
Paradigm Biopharmaceuticals AUD -5859230 3.79M 2024-12
Pharma Mar EUR -1054000 8.01M 2025-03
Polynovo AUD 2.86M 1.12M 2024-06
PYC Therapeutics AUD -25596250 3.68M 2024-12
Qiagen NV USD 170.75M 7.38M 2025-03
Ramsay Health Care AUD 1.02B 22.3M 2024-12
ResMed USD 473.14M 26.86M 2024-12
Sartorius EUR 263M 114.5M 2025-03
Sino Biopharmaceutical CNY 3.2B 955.21M 2024-12
Telix Pharmaceuticals AUD 54.7M 28.47M 2024-06
Tilray USD -101000 2.32M 2024-11
Zhangzhou Pientzehuang Pharmaceutical 1.19B 829.65M 2025-03



Avita Medical - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jun 2025.